TuHURA Biosciences (HURA) Prepaid Assets (2012 - 2026)
TuHURA Biosciences' (HURA) quarterly Prepaid Assets came in at $148985.0 in Q1 2026, down 69.44% year-on-year from $487464.0 in Q1 2025, and down 6.42% quarter-over-quarter from $159214.0 in Q4 2025.
TuHURA Biosciences (HURA) Prepaid Assets (2012 - 2026) Analysis & Trends
TuHURA Biosciences' Prepaid Assets history runs 15 years deep, the most recent figure standing at $148985.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 69.44% year-over-year to $148985.0 in Q1 2026; TTM through Mar 2026 was $148985.0, a 69.44% decrease from a year earlier, with the FY2025 full-year figure at $159214.0, down 83.39% from the prior year.
- Prepaid Assets slipped to $148985.0 in Q1 2026 per HURA's latest filing, from $159214.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.5 million in Q2 2022 and bottomed at $148985.0 in Q1 2026.
- The 5-year median for Prepaid Assets is $567000.0 (2023), against an average of $674941.4.
- Across the five-year window, Prepaid Assets soared 245.45% in 2022 and sank 83.39% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $1.1 million in 2022, then sank by 54.24% to $493769.0 in 2023, then jumped by 94.16% to $958708.0 in 2024, then sank by 83.39% to $159214.0 in 2025, then declined by 6.42% to $148985.0 in 2026.
- Per Business Quant, the three latest HURA Prepaid Assets figures stand at $148985.0 (Q1 2026), $159214.0 (Q4 2025), and $386775.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,985.00 |
| Dec 31, 2025 | 159,214.00 |
| Sep 30, 2025 | 386,775.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 487,464.00 |
| Dec 31, 2024 | 958,708.00 |
| Sep 30, 2024 | 258,000.00 |
| Jun 30, 2024 | 414,000.00 |
| Mar 31, 2024 | 208,000.00 |
| Dec 31, 2023 | 493,769.00 |
| Sep 30, 2023 | 567,000.00 |
| Jun 30, 2023 | 660,000.00 |
| Mar 31, 2023 | 821,000.00 |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 934,000.00 |
| Sep 30, 2021 | 769,000.00 |
| Jun 30, 2021 | 756,000.00 |